Found 9 matching trials
A Trial of NT-I7 in COVID-19 (SPESELPIS) PHASE1 The main purposes of this study is to determine the following in participan...
Show More Learn More & Join Trial
Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19 PHASE1 This study is a phase 1b clinical trial to investigate the safety and preli...
Show More Location
Borame Medical Center
Learn More & Join Trial
NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery PHASE1 This phase I trial evaluates the side effects of NT-I7 in treating patients...
Show More Location
University of California San Francisco
Learn More & Join Trial
NT-I7 for Kaposi Sarcoma in Patients With or Without HIV PHASE1 This phase I trial studies the best dose and effects of NT-I7 in treating K...
Show More Location
Zuckerberg San Francisco General Hospital
Learn More & Join Trial
Vaccine Response With NT-I7 PHASE1 Background:
People with cancer, and especially older people, have a weaken...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
A Study to Evaluate the Safety and Efficacy of GX-I7 in Elderly Patients With Asymptomatic or Mild Symptoms of COVID-19 PHASE2 This is a Phase 2 prospective, randomized, placebo-controlled, double-blind...
Show More Location
Mitra Keluarga Kelapa Gading
Learn More & Join Trial
A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia PHASE1 Background:
Idiopathic CD4 lymphopenia (ICL) is a syndrome characterized b...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma PHASE2 This phase II trial tests the safety and side effects of efineptakin alfa a...
Show More Learn More & Join Trial
NT-I7, a Long-Acting Recombinant IL-7 Molecule, as an Immune Reconstitution Strategy for Lymphopenia in Patients With Progressive Multifocal Leukoencephalopathy EARLY_PHASE1 Background:
Progressive multifocal leukoencephalopathy (PML) is a brain in...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial